Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418).

Yoo GS, Park W, Yu JI, Choi DH, Kim YJ, Shin KH, Wee CW, Kim K, Park KR, Kim YB, Ahn SJ, Lee JH, Kim JH, Chun M, Lee HS, Kim JS, Cha J.

Cancer Res Treat. 2018 Nov 1. doi: 10.4143/crt.2018.424. [Epub ahead of print]

2.

Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418).

Kim H, Park W, Yu JI, Choi DH, Huh SJ, Kim YJ, Lee ES, Lee KS, Kang HS, Park IH, Shin KH, Kim K, Park KR, Kim YB, Ahn SJ, Lee JH, Kim JH, Chun M, Lee HS, Kim JS, Lee JY.

Oncotarget. 2017 Jan 3;8(1):1796-1804. doi: 10.18632/oncotarget.12882.

3.

Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.

Wang J, Wang S, Tang Y, Jing H, Sun G, Jin J, Liu Y, Song Y, Wang W, Fang H, Ren H, Yu Z, Li Y.

Clin Breast Cancer. 2018 Oct;18(5):e975-e984. doi: 10.1016/j.clbc.2018.06.002. Epub 2018 Jun 27.

PMID:
30054238
4.

Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.

Kim K, Park HJ, Shin KH, Kim JH, Choi DH, Park W, Ahn SD, Kim SS, Kim DY, Kim TH, Kim JH, Kim J.

Cancer Res Treat. 2018 Oct;50(4):1316-1323. doi: 10.4143/crt.2017.575. Epub 2018 Jan 8.

5.

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

Abdulkarim BS, Cuartero J, Hanson J, Deschênes J, Lesniak D, Sabri S.

J Clin Oncol. 2011 Jul 20;29(21):2852-8. doi: 10.1200/JCO.2010.33.4714. Epub 2011 Jun 13.

6.

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis.

Chen K, Liu J, Zhu L, Su F, Song E, Jacobs LK.

Oncotarget. 2015 Nov 24;6(37):40127-40. doi: 10.18632/oncotarget.5394.

7.

[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].

Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.

Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25. Hungarian.

8.

Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy.

Onitilo AA, Engel JM, Stankowski RV, Doi SA.

Clin Med Res. 2015 Jun;13(2):65-73. doi: 10.3121/cmr.2014.1245. Epub 2014 Dec 8.

9.

Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study.

Kim H, Park W, Yu JI, Choi DH, Huh SJ, Kim YJ, Lee ES, Lee KS, Kang HS, Park IH, Shin KH, Wee CW, Kim K, Park KR, Kim YB, Ahn SJ, Lee JH, Kim JH, Chun M, Lee HS, Kim JS, Cha J.

Cancer Res Treat. 2017 Oct;49(4):970-980. doi: 10.4143/crt.2016.382. Epub 2017 Jan 4.

10.

Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

Brackstone M, Fletcher GG, Dayes IS, Madarnas Y, SenGupta SK, Verma S; Members of the Breast Cancer Disease Site Group.

Curr Oncol. 2015 Mar;22(Suppl 1):S54-66. doi: 10.3747/co.22.2316.

11.

Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.

Rakovitch E, Nofech-Mozes S, Hanna W, Sutradhar R, Gu S, Fong C, Tuck A, Youngson B, Miller N, Done SJ, Chang MC, Sengupta S, Elavathil L, Jani PA, Bonin M, Lalani N, Paszat L.

Breast. 2018 Feb;37:181-186. doi: 10.1016/j.breast.2017.07.002. Epub 2017 Aug 3.

PMID:
28781102
12.

Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?

Zaenger D, Rabatic BM, Dasher B, Mourad WF.

Clin Breast Cancer. 2016 Apr;16(2):101-4. doi: 10.1016/j.clbc.2015.11.005. Epub 2015 Nov 17.

PMID:
26718092
13.

The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.

Rusthoven CG, Rabinovitch RA, Jones BL, Koshy M, Amini A, Yeh N, Jackson MW, Fisher CM.

Ann Oncol. 2016 May;27(5):818-27. doi: 10.1093/annonc/mdw046. Epub 2016 Feb 9.

PMID:
26861597
14.
15.

Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.

Wai ES, Lesperance M, Lu L, Alexander CS, Truong PT.

Cureus. 2017 Mar 31;9(3):e1128. doi: 10.7759/cureus.1128.

16.

Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.

Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD.

J Clin Oncol. 1996 Jan;14(1):70-7.

PMID:
8558224
17.

The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.

Chen QX, Wang XX, Lin PY, Zhang J, Li JJ, Song CG, Shao ZM.

Oncotarget. 2017 Jan 17;8(3):4773-4780. doi: 10.18632/oncotarget.13976.

18.

Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).

Kim YJ, Park W, Ha B, Park B, Joo J, Kim TH, Park IH, Lee KS, Lee ES, Shin KH, Kim H, Yu JI, Choi DH, Huh SJ, Wee CW, Kim K, Park KR, Kim YB, Ahn SJ, Lee JH, Kim JH, Chun M, Lee HS, Kim JS, Cha J.

Cancer Res Treat. 2017 Oct;49(4):927-936. doi: 10.4143/crt.2016.508. Epub 2016 Dec 26.

19.

Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1062-73.

PMID:
15234040
20.

Adjuvant radiation after modified radical mastectomy for breast cancer fails to prolong survival.

Geisler DP, Boyle MJ, Malnar KF, Melichar RM, McGee JM, Nolen MG, Broughan TA.

Am Surg. 2000 May;66(5):452-8; discussion 458-9.

PMID:
10824745

Supplemental Content

Support Center